MX345862B - Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles. - Google Patents

Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles.

Info

Publication number
MX345862B
MX345862B MX2013010684A MX2013010684A MX345862B MX 345862 B MX345862 B MX 345862B MX 2013010684 A MX2013010684 A MX 2013010684A MX 2013010684 A MX2013010684 A MX 2013010684A MX 345862 B MX345862 B MX 345862B
Authority
MX
Mexico
Prior art keywords
methods
compositions
selenoglycoproteins
characterizing
separating
Prior art date
Application number
MX2013010684A
Other languages
English (en)
Other versions
MX2013010684A (es
Inventor
Kwiatkowski Stefan
Power Ronan
Matney Clayton
P Ghoroghchian Paiman
M Ostertag Eric
Original Assignee
Alltech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alltech Inc filed Critical Alltech Inc
Publication of MX2013010684A publication Critical patent/MX2013010684A/es
Publication of MX345862B publication Critical patent/MX345862B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a composiciones de selenio solubles y métodos de producción, separación y purificación de las mismas. Particularmente la presente invención proporciona métodos para preparar selenoglicoproteínas solubles en agua (por ejemplo, a través de extracción de selenoglicoproteínas de levadura enriquecida con selenio), métodos para suplementar una composición deficiente en selenio a través de la combinación de selenoglicoproteínas solubles en agua con la composición deficiente en selenio, composiciones que comprenden selenoglicoproteínas solubles en agua y métodos para administrar la misma.
MX2013010684A 2011-03-18 2011-09-16 Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles. MX345862B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/051,646 US8263752B2 (en) 2010-03-18 2011-03-18 Methods for separating soluble selenoglycoproteins
PCT/US2011/052022 WO2012128786A2 (en) 2011-03-18 2011-09-16 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins

Publications (2)

Publication Number Publication Date
MX2013010684A MX2013010684A (es) 2013-10-07
MX345862B true MX345862B (es) 2017-02-20

Family

ID=44911992

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010684A MX345862B (es) 2011-03-18 2011-09-16 Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles.

Country Status (21)

Country Link
US (1) US8263752B2 (es)
EP (1) EP2686416B1 (es)
JP (1) JP2014514277A (es)
KR (1) KR101571231B1 (es)
CN (1) CN103443265B (es)
AU (1) AU2011362979B2 (es)
CA (1) CA2828477C (es)
CL (1) CL2013002639A1 (es)
DK (1) DK2686416T3 (es)
EA (1) EA030339B1 (es)
EC (1) ECSP13012977A (es)
ES (1) ES2709623T3 (es)
IL (1) IL228085A0 (es)
MX (1) MX345862B (es)
MY (1) MY180517A (es)
NZ (1) NZ614634A (es)
PT (1) PT2686416T (es)
SG (1) SG193358A1 (es)
UA (1) UA114082C2 (es)
WO (1) WO2012128786A2 (es)
ZA (1) ZA201306419B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101632928B1 (ko) * 2014-06-07 2016-06-24 김우열 나노리포좀 액상 단미사료 제조방법 및 이에 제조된 액상 단미사료
KR101705320B1 (ko) * 2015-01-05 2017-02-10 주식회사이-글벳 생균수가 증가된 배지조성에 의한 발효사료의 제조방법 및 그 발효사료
CN107459563B (zh) * 2017-08-11 2020-06-19 广西壮族自治区农业科学院农业资源与环境研究所 一种提取硒蛋白过程中的沉淀工艺
CN112129864B (zh) * 2020-09-24 2022-04-01 江南大学 一种富硒植物干粉中硒形态测定的方法
CN116409758A (zh) * 2021-12-29 2023-07-11 中国农业科学院都市农业研究所 一种纳米硒的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57174098A (en) * 1981-04-17 1982-10-26 Sapporo Breweries Ltd Preparation of physiologically active proteinic polysaccharide seps containing selenium
US5221545A (en) 1992-03-09 1993-06-22 Abbott Laboratories Method of providing selenium in a nutritional product
JPH07300409A (ja) * 1994-04-28 1995-11-14 Ichimaru Pharcos Co Ltd セレン含有酵母の抽出エキスを含有する化粧料組成物
ATE246212T1 (de) 1995-05-26 2003-08-15 Igen Inc Molekular geprägten perl polymere und stabilisierte suspensionspolymerisation von diesen in perfluorkohlstoff flussigkeiten
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US6835394B1 (en) 1999-12-14 2004-12-28 The Trustees Of The University Of Pennsylvania Polymersomes and related encapsulating membranes
US7498045B2 (en) 2001-08-31 2009-03-03 Thomas M. S. Chang Biodegradable polymeric nanocapsules and uses thereof
DK174835B1 (da) 2002-03-15 2003-12-15 Pharma Nord Aps Selengærprodukt, fremgangsmåde til fremstilling af et selengærprodukt samt anvendelse af produktet til fremstilling af en fødevare, et kosttilskud, eller et lægemiddel
US6911550B2 (en) 2003-02-21 2005-06-28 Zinpro Corporation Derivatives of seleno-amino acids with improved bioavailability and method for their preparation
US7682603B2 (en) 2003-07-25 2010-03-23 The Trustees Of The University Of Pennsylvania Polymersomes incorporating highly emissive probes
US20050069594A1 (en) 2003-08-11 2005-03-31 Jan Lubinski Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer
JP5296531B2 (ja) 2005-05-05 2013-09-25 センシエント フレイバーズ エルエルシー βグルカン及びマンナンの製造
WO2007038763A1 (en) * 2005-09-28 2007-04-05 The Trustees Of The University Of Pennsylvania Self-assembled biodegradable polymersomes
US20070077238A1 (en) * 2005-10-04 2007-04-05 Teo Alex Y Production of organic and inorganic selenium compounds by lactic acid bacteria
JP4753683B2 (ja) * 2005-10-14 2011-08-24 オルテック インコーポレイテッド 細胞機能を変化させるための方法および組成物
CA2650309C (en) 2006-04-24 2014-08-19 Alltech, Inc. Selenium-containing compositions and use of the same
JP2008260823A (ja) * 2007-04-11 2008-10-30 Univ Of Fukui 亜セレン酸化多糖類およびその製造方法
CN101869183B (zh) * 2010-05-28 2013-03-20 广州立达尔生物科技股份有限公司 一种富硒酵母水解物及其生产方法

Also Published As

Publication number Publication date
IL228085A0 (en) 2013-09-30
AU2011362979A1 (en) 2013-09-12
BR112013023440A2 (pt) 2021-10-05
CA2828477C (en) 2017-02-21
MY180517A (en) 2020-12-01
NZ614634A (en) 2015-08-28
JP2014514277A (ja) 2014-06-19
MX2013010684A (es) 2013-10-07
KR101571231B1 (ko) 2015-11-23
EA030339B1 (ru) 2018-07-31
KR20130127525A (ko) 2013-11-22
ECSP13012977A (es) 2013-11-29
ZA201306419B (en) 2015-03-25
US20110280948A1 (en) 2011-11-17
CN103443265A (zh) 2013-12-11
US8263752B2 (en) 2012-09-11
CA2828477A1 (en) 2012-09-27
PT2686416T (pt) 2019-02-06
EP2686416A2 (en) 2014-01-22
CN103443265B (zh) 2016-06-29
EA201391340A1 (ru) 2014-07-30
UA114082C2 (xx) 2017-04-25
EP2686416A4 (en) 2014-11-12
DK2686416T3 (en) 2019-03-04
WO2012128786A3 (en) 2013-07-25
EP2686416B1 (en) 2018-11-07
ES2709623T3 (es) 2019-04-17
SG193358A1 (en) 2013-10-30
AU2011362979B2 (en) 2015-09-03
WO2012128786A2 (en) 2012-09-27
CL2013002639A1 (es) 2014-04-11

Similar Documents

Publication Publication Date Title
MX2019004378A (es) Edulcorante de estevia altamente soluble.
MY166016A (en) Infant nutrition for improving fatty acid composition of brain membranes
MX2014004078A (es) Bebidas nutricionales.
IN2015KN00262A (es)
IN2014CN04115A (es)
EA201490583A1 (ru) Удаление примесных вирусов из препаратов аав
EA201390039A1 (ru) Способ разделения газов
MD20150091A2 (ro) Compuşi antivirali
MX2014011818A (es) Anticuerpos biespecificos contra inductor debil de la apoptosis relacionado con el tnf (tweak) humana e il17 humana y usos de los mismos.
MY172073A (en) Bioactive botanical cosmetic compositions and processes for their production
IN2015DN03322A (es)
MX345862B (es) Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles.
GB201319839D0 (en) Synthesis and use of glycoside derivatives of propofol
IN2014KN00892A (es)
WO2014068586A3 (en) Solid oral compositions of tolvaptan
IN2014KN00893A (es)
GB201122408D0 (en) Method for preparing dry protein formulations
IN2015DN00085A (es)
MX2013013436A (es) Derivados de indol sustituidos para el tratamiento de transtornos inmunologicos.
MX2013014377A (es) Composiciones liquidas de alimento que comprenden proteina de suero de soja que se ha aislado de las corrientes de procesamiento.
GB2509476A (en) 18F - Fluciclovine compositions in citrate buffers
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
WO2013046233A3 (en) Process for the preparation of octreotide acetate
MY153904A (en) Method of producing pharmacologically pure crystals
UA65420U (ru) Композиция для внекорневой подкормки растений сахарной свеклы

Legal Events

Date Code Title Description
FG Grant or registration